$adgm short term perspective. I don’t think anything is happening in next week. They will get compliance back for stock price then expect offering or deal.
$400k float. PMA pending. Company seeking a sell. Let’s see what happens.
Look for 10q on Friday.
1
117
$adgm two options are ahead of Adagio:
1) offering to give runway for PMA approval & next gen trial results & time to work deal
2) Some type of structured deal that involves reworking their senior notes
Question: who wants their technology & what’s it worth?
IMO>$1.5 mil!
88
$adgm I’ll moderate my comments a bit: I think they are working towards some type of deal, capital restructuring/reverse merger. I presume some type of offering is involved. Bottom line is that this vote isn’t until Dec. What happens in between?
$adgm I’ve never seen a company ask for a 1/300 reverse split. Do a 1/30 reverse split. And then the day after it takes an effect, ask for a 1/1000 reverse split.
ALL THE WHILE THE COMPANY HAS NEVER ACTUALLY ISSUED ANY SHARES.
900k float. Asking for 1/1000 split. 😭🫠
104
$adgm
9/23 - 22 mil shares
10/1 - 27 mil shares
10/23 - Approve 1/10-1/300 r/s
11/9 - Do a 1/30 reverse split (900k shares
11/11 - Ask for a r/s up to 1/1000
They could announce bankruptcy & give stock a better chance to recover some value than their actions
@AdagioMedical
128
$adgm I’ve never seen a company ask for a 1/300 reverse split. Do a 1/30 reverse split. And then the day after it takes an effect, ask for a 1/1000 reverse split.
ALL THE WHILE THE COMPANY HAS NEVER ACTUALLY ISSUED ANY SHARES.
900k float. Asking for 1/1000 split. 😭🫠
$adgm using original PMA submission for PFA devices for AF, this is when you could expect Adagio’s PMA approval.
127
$adgm something interesting about this company. At every point they have signaled worse case and then delivered better than anticipated outcome.
Lowered conversion of convertible notes to 85% of 5 day VWAP from 9/23-10/31 > they only converted $700k for 5 mil shares
Asked for r/s approval of up to 1/500 > did a r/s for 1/30
Announced strategic review without a word about next gen trial > announced today it’s enrolled 20 people (55 patient trial)
They are currently still priced for worse case scenario! $adgm
$adgm priced like they are going bankrupt. Working like they have a plan. Which will it be?
finance.yahoo.com/healthcare…
1
173
$adgm its pretty wild management announced lower price conversion for 5 weeks (85% VWAP of 5 day low) and only converted $700k of $25 mil notes. They then asked for r/s of up to 1/500 and then only went 1/30. Incompetence or do they have a plan? 🤷♂️
1
287
$adgm PMA approval of first-gen device is big for proof of concept for their quicker and easier to use second-gen devoice.
312
$adgm this video now cuts two ways:
1) No one wants them. They will split and raise and hope they can prove themselves.
2) They may still have a chance to be bought or a partnership that validates their trajectory and leads to acquisition later.
1
170
$adgm dilution overhang ended on 10/31 with only 5 mil shares being added.
Perceptive still holds 10 mil of 27 mil shares.
PMA for 1st gen device could come any day this month or next.
192
$240k worth of shares traded today. Up slightly from the $15k that traded yesterday $adgm
Dilution
Bankruptcy or
Mispricing?
1
101
$adgm they likely can’t do more than a 1/30 split because of listing rules. This will be back under $1 (.03 pre split) right after they do a raise.
I think this one has done me in. ✌️
1
148
When you were tin foils hats… $adgm
$adgm tinfoil hat time:
9/8 - Sean Salmon comes on Teleflex board
9/16 - Adagio announces next gen trial first patient and now enrolling
9/23 - Adagio announces staff layoffs and strategic review
11/5 - Teleflex earnings
Acqusition, partnership, structured deal? 🤷♂️
175
$adgm tinfoil hat time:
9/8 - Sean Salmon comes on Teleflex board
9/16 - Adagio announces next gen trial first patient and now enrolling
9/23 - Adagio announces staff layoffs and strategic review
11/5 - Teleflex earnings
Acqusition, partnership, structured deal? 🤷♂️
Pre-FULCRUM data release but I think about these comments a lot! $ADGM
$adgm I’ve posted this before but found it interesting that it was posted again today by the Mullings Group. The video was taken before FULCRUM data. To post it following it is no small thing. Sean Salmon has chops in EP space and is on board at Adagio.
59






